Drugs (Price Control) Order 1995N P P A




FORM VI
(See paragraphs 2 and 20(2))

Yearly information on turnover and allocation of sales and expenses

1. Name of the manufacturer.
2. Address of the Registered/ Head Office/ Factory.
3. Accounting year.

Drugs (Price Control) Order 1995
• Definitions
• Fixation of Sale Prices
   of Bulk Drugs
• Bulk Drug Manufacturers
• Calculation of Retail Price
• Power to fix Formulation Prices
• Power to Fix Ceiling Price
• Power to recover Dues
• Power to recover Overcharged Amt.
• Issue of Price List
• Power to Review
• List of Price Controlled Drugs
• Application for Bulk
   Drug prices : Form I
• Information for non-Scheduled
   Bulk Drugs : Form II
• Application for Formulation
   Prices : Form III
• Form IV, V, VI
• The Third Schedule

4. Turnover of Bulk Drugs :-

Sl. No. Name of the Bulk Drug Unit Prod. Quality Captive Consumption
Quantity Value Excl. ED (Rs. Lakhs)
1. 2. 3. 4. 5. 6.
I. SCHEDULED BULK DRUGS
    1.
    2.
    3. etc.
II. NON-SCHEDULED BULK DRUGS
    1.
    2.
    3. etc.
TOTAL

Domestic Sale Exports
Quantity Sale Value Excl. ED (Rs. Lakhs) Quantity FOB Value (Rs. Lakhs)
7. 8. 9. 10.
 
   
   
   
 
   
   
   
 

5. Turnover of Formulations: -
Sl. No. Description Value of Domestic Sales excluding Excise Duty and Local Taxes (Rs. Lakhs) Exports FOB Value (Rs. Lakhs) TOTAL (Rs. Lakhs)
1. 2. 3. 4. 5.
I. SCHEDULED FORMULATIONS
1. Own Produced
2. Purchased
    (a) Indigenous
    (b) Imported
II. NON-SCHEDULED BULK DRUGS
1. Own Produced
2. Purchased
    (a) Indigenous
    (b) Imported
TOTAL

6. Allocation of sales and expenses as shown in the Audited Profit & Loss Account (In Rupees) Sl. No. Particulars Total as per P&L Account Allocation to Bulk Drugs Allocations to formulations Other Activities, if any Basis of Allocation Own Produced Purchased Export Sales Total Indigenous Imported 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. A. INCOME

  1. Sales Income (Excl. Excise duty and other taxes)
  2. Cash Subsidy (if any)
  3. Other Income (Incl. import incentives)
   TOTAL (1+2+3) B. EXPENSES
  1. Raw Materials
  2. Packing Materials
  3. Power & Fuel
  4. Salaries and Wages
  5. Stores and Spares
  6. Repair and Maintenance
  7. Insurance
  8. Depreciation
  9. Royalty
  10. Interest
  11. Head Office Expenses
  12. Dealer's Commission and Discount
  13. Research and Development Expenses
  14. Other Expenses
TOTAL (4 to 17) C. PROFIT BEFORE TAX (A-B)

D. PROFIT BEFORE TAX (As a %age of Sales Income)
[C X 100/A]

NOTES :

  • The basis of allocation should be reasonable and followed consistently.
  • The figures against S.NO. A under Cols. 4 to 9 of item 6 should tally with the figures under items 4 and 5 respectively of this Form.
  • This Form should be certified by the Company's Auditors.
The information furnished above is correct and true to the best of my knowledge and belief.

Authorised Signatory :
Place :
Name :
Date :
Designation :

Top of the Page | Home | Next